Rafferty Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Rafferty Asset Management's HRMY Position: Q3 2026 in Review
Rafferty Asset Management increased its Harmony Biosciences (HRMY) stake by 17% in Q3 2026, buying an estimated $37.7K and bringing the position to 6,574 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #1033.
Rafferty Asset Management first reported a position in HRMY in Q4 2021 and has held it in 9 quarters since. The position peaked at $281K in Q4 2021. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Rafferty Asset Management held 6,574 shares of Harmony Biosciences worth $258K as of Q3 2026.
- Rafferty Asset Management bought 976 Harmony Biosciences shares in Q3 2026, an estimated $37.7K.
- Harmony Biosciences made up ﹤0.01% of Rafferty Asset Management's portfolio in Q3 2026, its #1033 holding.
- Rafferty Asset Management first reported a position in Harmony Biosciences in Q4 2021 and has held it in 9 quarters since.
- Rafferty Asset Management's Harmony Biosciences position peaked at $281K in Q4 2021.
- 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.